| Company |
|
|
|
Group |
| 2020 |
2019 |
|
(R’million) |
Notes |
2020 |
2019 |
| |
|
A |
Cash operating profit |
|
|
|
| |
|
|
Operating profit/(loss) before abnormal items and impairment |
|
|
|
| 1 165,3 |
1 549,4 |
|
– Continuing operations |
|
2 601,6 |
3 170,3 |
| |
|
|
– Discontinued operations |
|
(503,1) |
(564,1) |
| |
|
|
Proceeds included in abnormal items |
|
– |
99,9 |
| |
|
|
Add back: |
|
|
|
| |
|
|
Depreciation |
|
780,0 |
621,6 |
| 16,2 |
– |
|
Expected credit losses |
|
118,2 |
– |
| |
|
|
Share-based payment expenses |
|
66,1 |
60,9 |
| |
|
|
Provision for post-retirement medical aid and pension fund |
|
(3,0) |
3,7 |
| |
|
|
Amortisation |
|
9,3 |
9,2 |
| |
|
|
Loss on disposal of plant, equipment and vehicles |
|
6,5 |
– |
| (1 184,5) |
(1 323,2) |
|
Dividends received from associate companies and subsidiaries |
|
|
|
| |
|
|
Restructuring and related costs paid |
|
(22,7) |
– |
| |
|
|
Legal settlements paid |
|
(47,2) |
– |
| 3,6 |
(0,3) |
|
Other non-cash items |
|
– |
– |
| 0,6 |
225,9 |
|
Cash operating profit |
|
3 005,7 |
3 401,5 |
| |
|
B |
Working capital changes |
|
|
|
| |
|
|
Decrease/(increase) in inventories |
|
60,3 |
(428,4) |
| (3,5) |
311,4 |
|
(Increase)/decrease in trade and other receivables |
|
(109,8) |
(89,7) |
| (0,8) |
4,0 |
|
Decrease/(increase) in trade and other payables |
|
(3,0) |
608,8 |
| (4,3) |
315,4 |
|
Working capital changes |
|
(52,5) |
90,7 |
| |
|
C |
Taxation paid |
|
|
|
| 2,5 |
0,2 |
|
Amounts (payable)/receivable at the beginning
of the year, net |
|
(12,8) |
(86,7) |
| |
|
|
Income statement charge |
|
|
|
| (21,3) |
(29,8) |
|
– Continuing operations |
8 |
(726,7) |
(965,0) |
| |
|
|
– Discontinued operations |
33 |
155,8 |
167,2 |
| |
|
|
Deferred tax |
17 |
(91,1) |
19,7 |
| |
|
|
Exchange rate difference and other non-cash items |
|
(7,2) |
– |
| (2,1) |
(2,5) |
|
Amounts payable/(receivable) at the end of the year, net |
|
61,7 |
12,8 |
| (20,9) |
(32,1) |
|
Total taxation paid |
|
(620,3) |
(852,0) |
| |
|
D |
Dividends paid |
|
|
|
| (823,8) |
(6 085,7) |
|
Per statement of changes in equity |
|
(739,8) |
(5 624,1) |
| – |
3 563,3 |
|
Dividend in specie on unbundling of Oceana |
|
– |
3 369,2 |
| |
|
|
Dividends paid to outside shareholders |
|
(0,8) |
(29,6) |
| (823,8) |
(2 522,4) |
|
Total dividends paid |
|
(740,6) |
(2 284,5) |
| |
|
E |
Purchase of property, plant, equipment |
|
|
|
| |
|
|
Replacement |
|
(658,8) |
(600,3) |
| |
|
|
Expansion |
|
(278,3) |
(503,2) |
| |
|
|
|
|
(937,1) |
(1 103,5) |
| |
|
F |
Cash and cash equivalents at the beginning of the year |
|
|
|
| 67,4 |
304,7 |
|
Cash resources |
|
1 723,9 |
1 581,1 |
| |
|
|
Short-term borrowings regarded as cash and cash equivalents |
|
(518,5) |
(911,9) |
| |
|
|
Discontinued operations |
|
(43,7) |
|
| 67,4 |
304,7 |
|
|
|
1 161,7 |
669,2 |
| |
|
G |
Cash and cash equivalents at the end of the year |
|
|
|
| 175,6 |
67,4 |
|
Cash resources |
|
1 790,0 |
1 723,9 |
| |
|
|
Short-term borrowings regarded as cash and |
|
|
|
| |
|
|
cash equivalents |
|
(2,0) |
(518,5) |
| |
|
|
Discontinued operations |
|
(8,5) |
(43,7) |
| 175,6 |
67,4 |
|
|
|
1 779,5 |
1 161,7 |
